Research explores inflammation-related cervical insufficiency and the clinical value of biomarkers, suggesting further validation is needed.
ConclusionCervical insufficiency is increasingly recognized as an inflammation-related syndrome. While novel biomarkers show promise for predicting outcomes, their clinical value must be further validated through large-scale, prospective, multicenter studies.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: